Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ajay Jaysingh Khopade"'
Publikováno v:
Journal of Pharmaceutical Innovation. 17:1247-1258
This study aims to formulate an ophthalmic gel-free reservoir (GFR) system for once-a-day (OD) delivery of timolol maleate for the treatment of glaucoma. The GFR system contains hydroxypropyl methylcellulose and polyvinylpyrrolidone mixed in ratios,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16204815afc7e3bfebbe4c38017327e5
https://doi.org/10.1007/s12247-021-09601-1
https://doi.org/10.1007/s12247-021-09601-1
Publikováno v:
Indian Journal of Clinical and Experimental Ophthalmology. 7:321-326
Purpose: This study was undertaken with an objective to compare the aqueous humor pharmacokinetics (PKs) of bimatoprost and bimatoprost free acid of innovator bimatoprost 0.01% (BAK-Bimatoprost) and the novel formulation, Tight Junction Modulation te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22bdfed36b82e23768e44fa34c363fcc
https://doi.org/10.18231/j.ijceo.2021.064
https://doi.org/10.18231/j.ijceo.2021.064
Autor:
Ajay Jaysingh Khopade, Arindam Halder
Publikováno v:
Clinical Ophthalmology. 14:3057-3064
Purpose Prostaglandin derivatives are used widely to reduce intraocular pressure associated with open-angle glaucoma. The most widely used prostaglandin derivative, latanoprost, is available in an ophthalmic solution that is solubilized and preserved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcc3b5bdd67bc0b080d56b819685d15e
https://doi.org/10.2147/opth.s266453
https://doi.org/10.2147/opth.s266453
Autor:
Arindam Halder, Ajay Jaysingh Khopade
Publikováno v:
Current eye research. 46(7)
Purpose: Many intraocular pressure (IOP)-lowering medications contain benzalkonium chloride (BAK), a preservative associated with unfavorable outcomes.A formulation of latanoprost 0.005% ophthalmic...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9ca48e60e2c5c338d6c14f1ea63b1d
https://pubmed.ncbi.nlm.nih.gov/33719796
https://pubmed.ncbi.nlm.nih.gov/33719796
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 9:1210
Background: This study was undertaken to compare the efficacy and safety of the new technology tight junction modulation (TJM) bimatoprost 0.01% (TJM-bimatoprost), containing polyhexamethylene biguanide hydrochloride as a preservative, and marketed b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bc538c8098a286fbf5a59c6526447d5
https://doi.org/10.18203/2319-2003.ijbcp20203087
https://doi.org/10.18203/2319-2003.ijbcp20203087